COVID-19患者福尔马林固定组织中的肝脏病理与SARS-CoV-2检测
本研究旨在检测COVID-19患者福尔马林固定组织块中的SARS-CoV-2,并记录其肝损伤模式,与对照组比较。结果显示,可在支气管肺泡细胞块(12/12,100%)、肺福尔马林固定石蜡包埋组织(8/8,100%)和肝脏(4/9,44%)中检测到病毒RNA;尽管COVID-19患者主要肝酶和胆红素峰值较高,但差异无统计学意义;主要组织学发现为轻微至局灶性轻度门管区慢性炎症(7/8,88%,P < .05)和轻度局灶性小叶活动(6/8,75%,P = .06)。结论:大多数死于COVID-19的患者有轻度局灶性肝炎的临床和组织学证据,但病毒检测阳性率不足半数。
要点
- COVID-19患者肝脏SARS-CoV-2 RNA检出率为44%(4/9)。
- 肝组织学以轻度门管区炎症(88%)和小叶活动(75%)为主。
- 肝酶和胆红素峰值较对照组升高但无统计学差异。
核心结论
- 大多数死于COVID-19的患者存在轻度局灶性肝炎的临床和组织学证据,但病毒在不足半数病例中可检测到。
研究设计与样本
- 检测COVID-19患者福尔马林固定组织块中的SARS-CoV-2,并与对照组比较肝损伤模式。
主要发现
- 支气管肺泡细胞块病毒RNA阳性12/12(100%),肺福尔马林固定石蜡包埋组织阳性8/8(100%),肝脏阳性4/9(44%)。
- COVID-19患者主要肝酶和胆红素峰值高于对照组,但差异无统计学意义。
- 主要组织学发现为轻微至局灶性轻度门管区慢性炎症(7/8,88%,P < .05)和轻度局灶性小叶活动(6/8,75%,P = .06)。
关键数值与推荐
- 肝脏SARS-CoV-2 RNA检出率44%(4/9)。
- 门管区慢性炎症7/8(88%),P < .05;小叶活动6/8(75%),P = .06。
- 支气管肺泡细胞块阳性12/12(100%),肺组织阳性8/8(100%)。
临床怎么用
- 对COVID-19死亡患者应关注轻度局灶性肝炎的临床和组织学表现。
- 福尔马林固定组织可用于SARS-CoV-2 RNA检测,但肝脏检出率有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The novel coronavirus, severe acute respiratory syndrome coronavirus 2, causing coronavirus disease 2019 (COVID-19) remains a global health threat and a significant source of human morbidity and mortality. While the virus primarily induces lung injury, it also has been reported to cause hepatic sequelae. METHODS: We aimed to detect the virus in formalin-fixed tissue blocks and document the liver injury patterns in patients with COVID-19 compared with a control group. RESULTS: We were able to detect viral RNA in the bronchioalveolar cell blocks (12/12, 100%) and formalin-fixed, paraffin-embedded tissue of the lung (8/8, 100%) and liver (4/9, 44%) of patients with COVID-19. Although the peak values of the main liver enzymes and bilirubin were higher in the patients with COVID-19 compared with the control group, the differences were not significant. The main histologic findings were minimal to focal mild portal tract chronic inflammation (7/8, 88%, P < .05) and mild focal lobular activity (6/8, 75%, P = .06). CONCLUSIONS: We found that most patients who died of COVID-19 had evidence of mild focal hepatitis clinically and histologically; however, the virus was detected in less than half of the cases.
引用
- Chornenkyy Y, Mejia-Bautista M, Brucal M, et al. Liver Pathology and SARS-CoV-2 Detection in Formalin-Fixed Tissue of Patients With COVID-19. Am J Clin Pathol. 2021. PMID: 33914058. doi:10.1093/ajcp/aqab009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。